SynthesisMedicine2019

Comparison of intravitreal bevacizumab and ranibizumab used for myopic choroidal neovascularization: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials.

Qiuming Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.